InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: cjgaddy post# 62852

Tuesday, 04/05/2011 11:52:40 AM

Tuesday, April 05, 2011 11:52:40 AM

Post# of 346073
Bavi plays well with others. So, it doesn't threaten the current SOC pharma. Bavi's adoption will not be limited by competitors protecting their turf. In fact it makes the current SOC drugs look even better. If Bavi continues to pan out in the trials, some smart pharma may make a lot of money selling it.

Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News